Additionally, a subgroup analysis showed that the GSTO2 polymorphism was significantly associated with an elevated risk of breast cancer (GG vs. AA), specifically in the homozygote, recessive, and allelic comparison model [46]. The gene discussed is GSTO2; the disease is breast cancer.